Thromboelastometric maximum clot firmness in platelet-free plasma is influenced by the assay used

Anesthesia and Analgesia

Volumn 117, Issue 1, 2013, Pages 23-29

  Schlimp, Christoph J ^a   Solomon, Cristina ^a,b   Hochleitner, Gerald ^b   Zipperle, Johannes ^a   Redl, Heinz ^a   Schöchl, Herbert ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b CSL BEHRING GMBH   (Germany)

^c AUVA Trauma Centre   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CYTOCHALASIN D; DIMETHYL SULFOXIDE; FRESH FROZEN PLASMA; THROMBOPLASTIN;

ARTICLE; BLOOD CLOT; BLOOD SAMPLING; HEMATOLOGICAL PROCEDURE; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; THROMBOCYTE FREE PLASMA; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; HUMANS; PLASMA; THROMBELASTOGRAPHY;

EID: 84880570339     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3182937b91     Document Type: Article

References (20)

1. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fbrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55
2. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011;15:R83
3. Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012;20:15
4. Schöchl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, Solomon C. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011;15:R265
5. Solomon C, Sørensen B, Hochleitner G, Kashuk J, Ranucci M, Schöchl H. Comparison of whole blood fbrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012;114:721-30
6. Kalina U, Stöhr HA, Bickhard H, Knaub S, Siboni SM, Mannucci PM, Peyvandi F. Rotational thromboelastography for monitoring of fbrinogen concentrate therapy in fbrinogen defciency. Blood Coagul Fibrinolysis 2008;19:777-83
7. Kawasaki J, Katori N, Kodaka M, Miyao H, Tanaka KA. Electron microscopic evaluations of clot morphology during thromb-elastography. Anesth Analg 2004;99:1440-4; table of contents
8. Lang T, Toller W, Gütl M, Mahla E, Metzler H, Rehak P, März W, Halwachs-Baumann G. Different effects of abciximab and cyto-chalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-53
9. Nielsen VG, Gurley WQ Jr, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by throm-belastography. Anesth Analg 2004;99:120-3
10. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safan RD. Monitoring platelet glycoprotein IIb/IIIa-fbrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130:401-11
11. Sørensen B, Fenger-Eriksen C, Christiansen K, Larsen OH, Ingerslev J. Evaluation of coagulation kinetics using throm-boelastometry-methodologic infuence of activator and test medium. Ann Hematol 2010;89:1155-61
12. Katori N, Tanaka KA, Szlam F, Levy JH. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fbrinolysis on thrombelastography. Anesth Analg 2005;100:1781-5
13. Theusinger OM, Madjdpour C, Spahn DR. Resuscitation and transfusion management in trauma patients: emerging concepts. Curr Opin Crit Care 2012;18:661-70
14. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA. Bleeding management with fbrinogen concentrate targeting a highnormal plasma fbrinogen level: a pilot study. Br J Anaesth 2009;102:785-92
15. Solomon C, Cadamuro J, Ziegler B, Schöchl H, Varvenne M, Sørensen B, Hochleitner G, Rahe-Meyer N. A comparison of fbrinogen measurement methods with fbrin clot elasticity assessed by thromboelastometry, before and after administration of fbrinogen concentrate in cardiac surgery patients. Transfusion 2011;51:1695-706
16. Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N. Recovery of fbrino-gen after administration of fbrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010;104:555-62
17. Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M. Thromboelastometry-guided administration of fbrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoab-dominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009;138:694-702
18. Ogawa S, Szlam F, Bolliger D, Nishimura T, Chen EP, Tanaka KA. The impact of hematocrit on fbrin clot formation assessed by rotational thromboelastometry. Anesth Analg 2012;115:16-21
19. Roeloffzen WW, Kluin-Nelemans HC, Bosman L, de Wolf JT. Effects of red blood cells on hemostasis. Transfusion 2010;50:1536-44
20. Solomon C, Rahe-Meyer N, Schochl H, Ranucci M, Gorlinger K. Effect of haematocrit on fbrin-based clot frmness in the FIBTEM test. Blood Transfus 2012 Nov 20:1-8. doi: 10.2450/2012.0043-12. [Epub ahead of print]